Aggressive basal cell carcinoma: Presentation, pathogenesis, and management

Cancer and Metastasis Reviews

Volumn 23, Issue 3-4, 2004, Pages 389-402

  Walling, Hobart W ^a   Fosko, Scott W ^b   Geraminejad, Pedram A ^a   Whitaker, Duane C ^a   Arpey, Christopher J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b S Louis Univ Hlth Sciences Center   (United States)

Author keywords

Bcl2; cryotherapy; curettage; cyclin; imiquimod; pyrimidine dimer

Indexed keywords

ANTINEOPLASTIC AGENT; CADHERIN; IMMUNOMODULATING AGENT; INTERSTITIAL COLLAGENASE; PROTEIN; STROMELYSIN; SYNDECAN 1;

BASAL CELL CARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CELL INFILTRATION; CELL SURVIVAL; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CORRELATION ANALYSIS; CYTOGENETICS; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE MUTATION; HISTOLOGY; HUMAN; METASTASIS; MOLECULAR MECHANICS; PATHOGENESIS; PERINEURIUM; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TUMOR VOLUME;

CARCINOMA, BASAL CELL; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; RECURRENCE; RISK FACTORS;

EID: 3042818253     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CANC.0000031775.04618.30     Document Type: Review

References (139)

1. Diepgen T, Mahler V: The epidemiology of skin cancer. Br J Dermatol 146, S61: 1-6 S, 2002
2. Chuang T, Popescu A, Su WP, Chute CG: Basal cell carcinoma: A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 22: 413-417, 1990
3. Gallagher R, Ma B, McLean D, Yang CP, Ho V, Carruthers JA, Warshawski LM: Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973-1987. J Am Acad Dermatol 23: 413-421, 1990
4. Coebergh J, Neumann HAM, Vrints LW, Van Der Heijden L, Meijer WJ, Verhagen-Teulings MT: Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988, a registry-based study. Brit J Dermatol 125: 353-359, 1991
5. Ko C, Walton S, Keczkes K, Bury HPR, Nicholson C: The emerging epidemic of skin cancer. Brit J Dermatol 130: 269-272, 1994
6. Miller D, Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 30: 774-778, 1994
7. Marcil I, Stern RS: Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Arch Dermatol 136: 1524-1530, 2000
8. Kricker A, Armstrong BK, English DR, Heenan PJ: A dose-response curve for sun exposure and basal cell carcinoma. Int J Cane 60: 482-488, 1995
9. Rosso S, Zanetti R, Pippione M, Sancho-Garnier H: Parallel risk assessment of melanoma and basal cell carcinoma: Skin characteristics and sun exposure. Melanoma Res 8: 573-583, 1998
10. Lock-Andersen J, Drzewiecki KT, Wulf HC: Eye and hair color, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma: A Danish case-control study. Acta Derm Venereol 79: 74-80, 1999
11. von Domarus H, Stevens PJ: Metastatic basal cell carcinoma: Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10: 1043-1060, 1984
12. Jackson R, Adams RH: Horrifying basal cell carcinoma: A study of 33 cases and a comparison with 435 nonhorror and a report on 4 metastatic cases. J Surgical Oncology 5: 431-463, 1973
13. Blewitt R: Why does basal cell carcinoma metastasize so rarely? J Dermatol 19: 146-148, 1980
14. Randle H: Basal cell carcinoma: Identification and treatment of the high risk patient. Dermatol Surg 22: 255-261, 1996
15. Batra RaKL: Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 138: 1043-1051, 2002
16. Roenigk R, Ratz LJ, Bailin PL, Wheeland RG: Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg & Oncol 12(8): 860-865, 1986
17. Mora R, Robins, P: Basal cell carcinomas in the center of the face: Special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg 4: 315, 1978
18. Vico P, Fourez T, Nemec E, Andry G, Deraemaecker R: Aggressive basal cell carcinoma of the head and neck areas. Euro J Surg Oncol 21(5): 490-497, 1995
19. Wallberg P, Kaaman T, Lindberg M: Multiple basal cell carcinoma: A clinical evaluation of risk factors. Acta Derm Venereol (Stockh) 78: 127-129, 1998
20. Leffell D, Headington JT, Wong DS, Swanson NA: Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 127(11): 1663-1667, 1991
21. Roudier-Pujol C, Auperin A, Nguyen T, Duvillard P, Benhamou E, Avril M: Basal cell carcinoma in young adults: Not more aggressive than in older patients. Dermatol 199: 119-123, 1999
22. Scrivener Y, Grosshans E, Cribier B: Variations of basal cell carcinomas according to gender, age, location, and histopathological subtype. Br J Dermatol 147: 41-47, 2002
23. Richmond J, Devie RM: The significance of incomplete excision in patients with basal cell carcinoma. Brit J Plast Surg 40: 63-67, 1987
24. Griffiths R: Audit of histologically incompletely excized basal cell carcinomas: Recommendations for management by re-excision. Brit J Plast Surg 52: 24-28, 1999
25. Lever W, Schaumburg-Lever G: Histopathology of the skin. Philadelphia, Lippincott, 622-634, 1990
26. Sexton M, Jones DB, Maloney ME: Histologic pattern analysis of basal cell carcinoma. J Am Acad Dermatol 23: 1118-1126, 1990
27. Lo J, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ: Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature. J Am Acad Dermatol 24(5): 715-719, 1991
28. Preston D, Stern RS: Nonmelanoma cancers of the skin. New England J Med 327: 1649-1662, 1992
29. Siegle R, Macmillan J, Pollack SV: Infiltrative basal cell carcinoma: A nonsclerosing subtype. J Dermatol Surg Oncol 12: 830-836, 1986
30. de Faria J: Basal cell carcinoma of the skin with areas of squamous cell carcinoma: A basosquamous cell carcinoma. J Clin Pathol 38: 1273-1277, 1985
31. Hendrix JJ, Parlette HL: Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension. Arch Dermatol 132: 295-298, 1996
32. Richman TaPN: Analysis of morpheaform basal cell carcinoma. J Cutan Path 15: 359-362, 1988
33. Brown C, Perry AE: Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopath 22: 123-125, 2000
34. Wrone D, Swetter SM, Egbert BM, Smoller BR, Khavari PA: Increased proportion of aggressive-growth basal cell carcinoma in the Veteran's Affairs population of Palo Alto, California. J Am Acad Dermatol 35: 907-910, 1996
35. Betti R, Inselvini E, Carducci M, Crosti C: Age and site prevalence of histologic subtypes of basal cell carcinomas. Int J Dermatol 34: 174-176, 1995
36. McCormack C, Kelly JW, Dorevitch AP: Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. Arch Dermatol 133: 593-596, 1997
37. Bastiaens M, Hoefnagel JJ, Bruijn JA, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN: Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 110: 880-884, 1998
38. Salasche S, Amontette RA: Morpheaform basal-cell epitheliomas. J Dermatol Surg Oncol 7: 387-394, 1981
39. Tromovitch T, Stegman SJ: Microscopic-controled excision of cutaneous tumors. Cancer 41(2): 653-658, 1978
40. Levine H, Bailin PL: Basal cell carcinoma of the head and neck: Identification of the high-risk patient. Laryngoscope 90: 955-961, 1980
41. Jacobs G, Rippley JJ, Altini M: Prediction of aggressive behavior in basal cell carcinoma. Cancer 49: 533-537, 1982
42. Lang P, Maize JC: Histologic evolution of recurrent basal cell carcinoma and treatment implication. J Am Acad Dermatol 14: 186-196, 1986
43. Sloane J: The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Brit J Dermatol 96: 127-132, 1977
44. Hendrix JJ, Parlette HL: Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case control study. Dermatol Surg 22: 535-539, 1996
45. Horlock N, Wilson GD, Daley FM, Richman PI, O Grobbelaar A, Sanders R, Foy C: Cellular proliferation characteristics do not account for the behavior of horrifying basal cell carcinoma. A comparison of the growth fraction of horrifying and nonhorrifying tumors. Brit J Plast Surg 51: 59-66, 1998
46. Borel D: Cutaneous basosquamous carcinoma: Review of the literature and report of 35 cases. Arch Path 95: 293, 1973
47. Farmer E, Helwig EB: Metastatic basal cell carcinoma. Cancer 46: 748-757, 1980
48. Tavin E, Persky MS, Jacobs, J: Metastatic basal cell carcinoma of the head and neck. Laryng 105: 814-817, 1995
49. Martin RN, Edwards MJ, Cawte TG, Sewell CL, McMasters KM: Basosquamous carcinoma: Analysis of prognostic factors influencing recurrence. Cancer 88: 1365-1369, 2000
50. Orengo I, Salasche SJ, Fewkes J, Khan J, Thornby J, Rubin F: Correlation of histological subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane. J Am Acad Dermatol 37: 395-397, 1997
51. Miller P, Roenigk RK, Brodland DG, Randle HW: Cutaneous micrographic surgery: Moh's procedure. Mayo Clinic Proceedings 67: 971-980, 1992
52. Barrett T, Greenway HT Jr., Massullo V, Carlson C: Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion. Adv Dermatol 8: 277-305, 1993
53. Terashi H, Kurata S, Tadokoro T, Ishii Y, Sato H, Kudo Y, Katagiri K, Itami S, Takayasu S: Perineural and neural involvement in skin cancers. Dermatol Surg 22: 259-265, 1997
54. Snow S, Saul WJ, Lo J, Mohs FE, Warner T, Dekkinga JA, Feyzi J: Metastatic basal cell carcinoma: Report of 5 cases. Cancer 73(2): 328-335, 1994
55. Ratner D, Lowe L, Johnson TM, Fader DJ. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 88: 1605-1613, 2000
56. Niazi ZB LB: Perineural infiltration in basal cell carcinomas. Br J Plast Surg 46(156-157), 1993
57. Boothman D, Lee IW, Sahijdak WM: Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: Potential uses of X-ray-responsive elements for gene therapy. Radiat Res 138: S68-71, 1994
58. Boothman D, Fukunaga N, Wang M: Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Res 54: 4618-4626, 1994
59. Staibano S, Boscaino A, Salvatore G, Orabona P, Palombini L, and DeRosa G: Prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Path 27: 695-700, 1996
60. Kerkela E, Ala-aho R, Lohi J, Grenman R, M-Kahari V, Saarialho-Kere U: Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 84: 659-669, 2001
61. Dumas V, Kanitakis J, Charvat S, Euvrard S, Faure M, Claudy A: Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous and squamous carcinomas. Anticancer Res 19: 2929-2938, 1999
62. Varani J, Hattori Y, Chi Y, Schmidt T, Perone P, Zeigler ME, Fader DJ, Johnson TM: Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of the skin: Comparison with normal skin. Br J Cancer 82: 657-665, 2000
63. Johansson N, Ahonen M, Kahari VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57: 5-15, 2000
64. Tsukifuji R, Sakai Y, Hatamochi A, Shinkai H: Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase. Histo J 29(5): 401-407, 1997
65. Cribier B, Noacco G, Peltre B, Grosshans E: Expression of stromelysin 3 in basal cell carcinomas. European J Dermatol 11: 530-533, 2001
66. Majmudar G, Nelson BR, Jensen TC, Johnson TM: Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcino 9(1): 29-33, 1994
67. Basset P, Bellocq JP, Lefebvre O, Noel A, Chenard MP, Wolf C, Angland P, Rio MC: Stromelysin-3: A paradigm for stroma-derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol 26: 43-53, 1997
68. Bayer-Garner I, Dilday B, Sanderson RD, Smoller BR: Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma. Am J Dermatopathol 22: 119-122, 2000
69. Christian M, Moy RL, Wagner RF, Yen-Moore A: A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma. Dermatol Surg 27: 441-445, 2001
70. Takeuchi T, Liang SB, Ohtsuki Y: Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol Carcinog 35: 173-179, 2002
71. Schuller D, Berg JW, Sherman G, Krause CJ: Cutaneous basosquamous carcinoma of the head and neck: a comparative analysis. Otolaryng & Head & Neck Surg 87: 420-427, 1979
72. Rowe D, Carroll RJ, Day CL Jr.: Long-term recurrence rate in previously untreated primary basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol 15: 315-328, 1989
73. Silverman M, Kopk AW, Bart RS, Grin CM: Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg & Oncol 18(6): 471-476, 1992
74. Robinson J, Fisher SG: Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 136: 1318-1324, 2000
75. Robinson J: Risk of developing another basal cell carcinoma: A 5-year prospective study. Cancer 60: 118-120, 1987
76. Levi F, La Veechia C, Te V-C, Randimbison L, Erler G: Incidence of invasive cancers following basal cell skin cancer. Am J Epid 147(8): 722-726, 1998
77. Conley J, Sachs ME, Romo T, Labay G, Gillooley J: Metastatic basal cell carcinoma of the head and neck. Otolaryng - Head & Neck Surg 93: 78-85, 1985
78. Henke A, Wiemerslage SJ, Cohen MB: Cytology of metastatic cutaneous basal cell carcinoma. Diagn Cytopathol 19: 113-115, 1998
79. Domasus H, Stevens P: Metastatic basal cell carcinoma: Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10: 1043-1060, 1984
80. Lopes de Faria J, Nunes PH: Basosquamous cell carcinoma of the skin with metastases. Histopath 12(1): 85-94, 1988
81. Talmi Y, Gal R, Finkelstein Y, Nobel M, Shvilli I, Zohar Y: Squamous and basal cell cancers directly invading major salivary glands. Ann Plast Surg 26(5): 483-487, 1991
82. Frizelle F, Massey R, Pettigrew RA: Metastatic basal cell carcinoma: Case report. Euro J Surg 161: 369-372, 1995
83. Berti J, Sharata HH: Metastatic basal cell carcinoma to the lung. Cutis 63: 165-166, 1999
84. Stanley M, Bardales RH, Farmer CE, Frierson HF Jr., Suhrland M, Powers CN, Rollins SD: Primary and metastatic high-grade carcinomas of the salivary glands: A cytological-histological correlation study of twenty cases. Diagnos Cytopathol 13(1): 37-43, 1995
85. Stanley M, Horwitz CA, Bardales RH, Stern SJ, Korourian S: Basal cell carcinoma metastatic to the salivary glands: Differential diagnosis in fine-needle aspiration cytology. Diagnos Cytopathol 16(3): 247-252, 1997
86. Baker P, Berggren R: Metastatic basal cell carcinoma: Review and report of a case. Ann Plast Surg 11(5): 428-430, 1983
87. Fasika O, Shokunbi MT: Metastatic basal cell carcinoma of the spine. Cen Afri J Med 42(3): 76-77, 1996
88. Lam D, Ragoowansi R, Powell BW: Basal cell carcinoma of the scalp with spinal metastasis. J R Soc Med 91: 539-540, 1998
89. Gall C, Buttner A, Bise K, Steiger H-J: Primary intracranial metatypical basal cell carcinoma: Case report. Neurosurgery 41(1): 279-282, 1997
90. Ambros R, Standiford SB, Sobel HJ, Haim A, Mohit-Tabatabai MA: Rapid development of metastases from basal cell carcinoma presenting as cranial nerve palsies. J Dermatol Surg & Oncol 14(2): 1410-1412, 1988
91. Sitz K, Kappen M, Johnson, D: Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex. J Am Med Assoc 257: 340-343, 1987
92. Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, Falcini F, Zanetti R, Barchielli A, Serraino D, Rezza G: Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Brit J Canc 78(7): 966-970, 1998
93. Sahl W, Snow SN, Levine NS: Giant basal cell carcinoma: Report of two cases and review of the literature. J Am Acad Dermatol 30: 856-859, 1994
94. Rasezewski R, Guyuron B: Long-term survival following nodal metastases from basal cell carcinoma. Ann Plastic Surgery 24: 170-175, 1990
95. Grossman D, Leffell DJ: The molecular basis of nonmelanoma skin cancer: New understanding. Arch Dermatol 133: 1263-1270, 1997
96. LaCour J: Carcinogenesis of basal cell carcinomas: Genetics and molecular mechanisms. Br J Dermatol 146(S61): 17-19, 2002
97. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, Lear JT, Heagerty AH, Bowers B, Hand P, Hayes JD, Jones PW, Strange RC, Fryer AA: Polymorphism at the glutathione S-transferase, GSTM3 locus: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Research 56(9): 1974-1977, 1996
98. Heagerty A, Smith A, English J, Lear J, Perkins W, Bowers B, Jones P, Gilford J, Alldersea J, Fryer A, Strange RC: Susceptibility to multiple cutaneous basal cell carcinomas: Significant interactions between glutathione-S-transferase GSTM1 genotypes, skin type, and male gender. Brit J Canc 73(1): 44-48, 1996
99. Van der Schroeff J, Evers LM, Boot AJM, Bos JL: Ras oncogene point mutations in basal cell carcinomas and squamous cell carcinomas of the human skin. J Invest Dermatol 94: 423-425, 1990
100. Urabe A, Nakayama J, Taniguchi S, Kuroki R, Hori Y: Expression of the fos oncogene in basal cell carcinoma. J Dermatol Sci 8: 50-53, 1994
101. Jin Y, Martins C, Salemark L, Persson B, Jin C, Miranda J, Fonseca I, Jonsson N: Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet 131: 109-119, 2001
102. De Rosa G, Vetrani A, Zeppa P, Zabatta A, Barra E, Gentile R, Fulciniti F, Troncone G, di Benedetto G, Palombini L: Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer 65: 544-549, 1990
103. De Rosa G, Staibano S, Barra E, Zeppa P, Salvatore G, Vetrani A, Palombini L: Nucleolar organizer regions in aggressive and nonaggressive basal cell carcinoma of the skin. Cancer 69: 123-126, 1992
104. De Rosa G, Barra E, Guarino M, Staibano S, Donofrio V, Boscaino A: Fibronectin, laminin, type IV collagen distribution, and myofibroblastic stromal reaction in aggressive and nonaggressive basal cell carcinoma. Am J Dermatopath 16: 258-267, 1994
105. Staibano S, Lo Muzio L, Mezza E, Argenziano G, Tornillo L, Pannone G, De Rosa G: Prognostic value of apoptotic index in cutaneous basal cell carcinomas of the head and neck. Oral Oncol 35: 541-547, 1999
106. Murphy M, Mabruk MJ, Lenane P, Liew A, McCann P, Buckley A, Flatharta CO, Hevey D, Billet P, Robertson W, Javed S, Leader M, Kay E, Murphy GM: Comparison of the expression of p53, p21, Bax, and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation. J Clin Pathol 55: 829-833, 2002
107. Soehnge H, Ouhit A, Anathaswamy HN: Mechanisms of induction of skin cancer by UV radiation. Front Biosci 2: 538-551, 1997
108. De Rosa G, Staibano S, Barra E, Donofrio V, Salvatore G, Vessecchia G, Boscaino A: p53 protein in aggressive and nonaggressive basal cell carcinoma. J Cutaneous Pathol 20: 429-434, 1993
109. Crowson A, Magro CM, Kadin ME, Stranc M: Differential expression of the bcl-2 oncogene in human basal cell carcinoma. Human Pathology 27(4): 355-359, 1996
110. Auepemkiate S, Boonyaphiphat P, Thongsuksai P: p53 expression related to the aggressive infiltrative histopathologic feature of basal cell carcinoma. Histopathol 40: 568-573, 2002
111. Boonchai W, Walsh M, Cummings M, Chenevix-Trench G: Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Arch Dermatol 136: 195-198, 2000
112. Ramdial P, Madaree A, Reddy R, Chetty R: bcl-2 protein expression in aggressive and nonaggressive basal cell carcinomas. J Cutaneous Pathol 27: 283-291, 2000
113. Staibano S, Lo Muzio L, Pannone G, Scalvenzi M, Salvatore G, Errico ME, Fanali S, De Rosa G, Piattelli A: Interaction between bcl-2 and p53 in neoplastic progression of basal cell carcinoma of the head and neck. Anticancer Research 21: 3757-3764, 2001
114. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, Zhang X, Scott MP, Epstein EH, Jr.: Identification of mutations in the human patched gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 110: 885-888, 1998
115. Bodak N, Queille S, Avril MF, Bouadjar B, Drougard C, Sarasin A, Daya-Grosjean L: High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosa. Proc Natl Acad Sci USA 96: 5117-5122, 1999
116. Smythe I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C, Wainwright BJ: Isolation and characterization of human Patched 2 (PTCH2), a putative tumor suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Gen 8: 291-297, 1999
117. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein EH Jr., deSavage FJ: Activating smoothened mutations in sporadic basal cell carcinomas. Nature 391: 90-92, 1998
118. Thissen M, Neumann MHA, Schouten LJ: A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135: 1177-1183, 1999
119. Alecu M, Ursaciuc C, Halalau F, Coma G, Merlevede W, Waelkens E, de Witte P: Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Research 18: 4651-4654, 1998
120. Soler A, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J, Giercksky KE: Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: A comparison of two light sources. Photochem, Photobiol 71: 724-729, 2000
121. Khandekar J: Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: A report on two patients. Arch Dermatol 126(12): 1660, 1990
122. Moeholt K, Aagaard H, Pfeiffer P, Hansen O: Platinum-based cytotoxic therapy in basal cell carcinoma - a review of the literature. Acta Oncologica 35(6): 677-682, 1996
123. Denic S: Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol - Cancer Clin Trials 22: 32-34, 1999
124. Kuijpers D, Thissen MR, Neumann MH: Basal cell carcinoma: Treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 3: 247-259, 2002
125. Weinstock M, Bogaars HA, Ashley M, Litle V, Bilodeau E, Kimmel S: Non-melanoma skin cancer mortality: A population-based study. Arch Dermatol 127(8): 1194-1197, 1991
126. McGillis S, Whellan RG, Sebben JE: Current issues in the performance of Mohs micrographic surgery. J Dermatol Surg & Oncol 9: 777-788, 1991
127. Woerle B, Heckmann M, Konz B: Micrographic surgery of basal cell carcinomas of the head. Recent Results Cancer Res 160: 219-224, 2002
128. Telfer N: Mohs micrographic surgery for nonmelanoma skin cancer. Clin Dermatol 13: 593-600, 1995
129. Rowe D, Carroll RJ, Day CL Jr.: Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15: 424-431, 1989
130. Mallon E, Dawber R: Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg 22: 854-858, 1996
131. Jaramillo-Ayerbe F: Cryosurgery in difficult to treat basal cell carcinoma. Int J Dermatol 39: 223-229, 2000
132. Thissen M, Nieman FH, Ideler AH, Berretty PJ, Neumann HA: Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 26: 759-764, 2000
133. Werlinger K, Upton G, Moore AY: Recurrence rates of primary nonmelanoma skin cancers trated by surgical excision compared to electrodesiccation- curettage in a private dermatological practice. Dermatol Surg 28: 1138-1142, 2002
134. Avril M-F, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume J-C, Chalon R, Petit J-Y, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D: Basal cell carcinoma of the face: Surgery or radiotherapy? Results of a randomized study. Brit J Canc 76(1): 100-106, 1997
135. Smith S, Foley EH, Grande DJ: Use of Moh's micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy. Journal Dermatol Surg Oncol 16: 1012-1016, 1990
136. Koplin L, Zarem HA: Recurrent basal cell carcinoma. Plastic Reconstr Surg 65: 656, 1980
137. Geisse J, Rich P, Pandya A, Gross K, Andres K, Ginkel A, Owens M: Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle controlled study. J Am Acad Dermatol 47: 390-398, 2002
138. DiGiovanna J: Retinoid chemoprevention in patients at high risk for skin cancer. Med Pediatr Oncol 36: 564-567, 2001
139. Bialy T, Rothe MJ, Grant-Kels JM: Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. Dermatol Surg 28: 1143-1152, 2002